The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...
Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
Bouygues has launched a new Construction Division as of 1 January 2026, объединing Colas, Bouygues Construction and Bouygues Immobilier under the leadership of Pascal Minault to strengthen ...
About Kinaset Therapeutics, Inc. Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. With founding investors 5AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback